Publications:

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research

Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H

Publication Date: 2022-01

Variant appearance in text: KMT2C: Y4884C

PubMed Link: 34963661

Variant Present in the following documents:

• supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3

View BVdb publication page

Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.

Cancer Discovery

Kato, Shinichiro S; Weng, Qing Yu QY; Insco, Megan L ML; Chen, Kevin Y KY; Muralidhar, Sathya S; Pozniak, Joanna J; Diaz, Joey Mark S JMS; Drier, Yotam Y; Nguyen, Nhu N; Lo, Jennifer A JA; van Rooijen, Ellen E; Kemeny, Lajos V LV; Zhan, Yao Y; Feng, Yang Y; Silkworth, Whitney W; Powell, C Thomas CT; Liau, Brian B BB; Xiong, Yan Y; Jin, Jian J; Newton-Bishop, Julia J; Zon, Leonard I LI; Bernstein, Bradley E BE; Fisher, David E DE

Publication Date: 2020-07

Variant appearance in text: MLL3: Y4884C

PubMed Link: 32269030

Variant Present in the following documents:

• Main text

View BVdb publication page

Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme.

Clinical Epigenetics

Weirich, Sara S; Kudithipudi, Srikanth S; Kycia, Ina I; Jeltsch, Albert A

Publication Date: 2015

Variant appearance in text: MLL3: Y4884C

PubMed Link: 25829971

Variant Present in the following documents:

• Main text
• 13148_2015_75_MOESM1_ESM.pdf
• 13148_2015_Article_75.pdf

View BVdb publication page